See every side of every news story
Published loading...Updated

Surrozen raises $175M, to focus on ophthalmology; CBC Group has a new $1B fund

Summary by Endpoints News
Plus, news about CG Oncology, Opus Genetics and Valneva: Surrozen’s pivot and capital raise: The South San Francisco drug developer is scrapping clinical development in severe alcohol associated hepatitis and instead ...

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Globe Newswire broke the news in on Monday, March 24, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.